Biography

Dr Feizpour holds a Ph.D. in neuroscience and an M.Sc. in medical physiology. She completed her PhD at Monash University in 2018 with a focus on frontal visual association and orbitofrontal regions to study visual and goal-directed behaviour. Following completion of her doctoral studies, she transitioned to the med-tech industry where she gained more than 3 years of experience in translational research. During this period, she was appointed to the position of Chief Scientist at TALi Health Pty. Ltd., a neuroscience technology company developing digital diagnostics and therapeutics for neurodevelopmental disorders. She is passionate about utilizing digital and other emerging technologies to deliver research-informed innovations that offer effective, targeted, and safe diagnostics and interventions for patients with neurodevelopmental and/or neurodegenerative disorders. Dr Feizpour joined The Florey Institute of Neuroscience and Mental Health as a Senior Research Fellow in  2022 to collaborate with clinicians and researchers on the AIBL and ADNeT studies and contributes to research on emerging Alzheimer's disease diagnostics and their translation into clinical practice. She is currently analysing the AIBL and ADNeT datasets to provide a better understanding about the prognostic utility of blood biomarkers in the Alzheimer’s Disease continuum.